Generic Version Of J&J Pain Patches Recalled

Law360, New York (February 19, 2008, 12:00 AM EST) -- Another batch of patches containing the strong painkiller fentanyl has been pulled from store shelves over concerns that a design flaw could lead to a fatal overdose in patients or caregivers.

Actavis South Atlantic LLC, formerly known as Abrika Pharmaceuticals Inc., voluntarily recalled on Monday its generic pain-treatment patches sold in the United States, just days after a Johnson & Johnson subsidiary yanked its Duragesic patches off the market.

The company said the prescription patches were recalled as a precaution due to a fold-over defect that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.